P. Reinke

Universität Hamburg — Germany

Computer Science · Physical Sciences

12h-index837citations64works2.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Computational Drug Discovery Methods(26), SARS-CoV-2 and COVID-19 Research(23), interferon and immune responses(8), Enzyme Structure and Function(6), Synthesis and biological activity(4)

Publications64 total

The Single-Particle, Clusters and Biomolecules and Serial Femtosecond Crystallography instrument of the European X-ray Free-Electron Laser: Interaction Region Downstream at atmospheric pressure (IRD)
Journal of Synchrotron Radiation·2025Open Access
Room-temperature X-ray fragment screening with serial crystallography
Nature Communications·2025· 1 citedOpen Access
Enhancing the outcome of crystallographic screening for efficient drug discovery by choosing the right crystal form
2025Open Access
3D atomic structure determination with ultrashort-pulse MeV electron diffraction
arXiv (Cornell University)·2025Open Access
Statistical crystallography reveals an allosteric network in SARS-CoV-2 M <sup>pro</sup>
2025· 2 cited
Crystal structures of cables formed by the acetylated and unacetylated forms of the Schizosaccharomyces pombe tropomyosin ortholog TpmCdc8
Journal of Biological Chemistry·2024· 2 citedOpen Access
Accelerator based 3D structure determination with MeV electrons
Acta Crystallographica Section A Foundations and Advances·2024Open Access
SARS-CoV-2 Mpro responds to oxidation by forming disulfide and NOS/SONOS bonds
Nature Communications·2024· 8 citedOpen Access
Structural Elucidation and Antiviral Activity of Covalent Cathepsin L Inhibitors
Journal of Medicinal Chemistry·2024· 11 citedOpen Access
Time-resolved crystallography captures light-driven DNA repair
Science·2023· 58 citedOpen Access
Calpeptin is a potent cathepsin inhibitor and drug candidate for SARS-CoV-2 infections
Communications Biology·2023· 13 citedOpen Access
High-throughput screening on the PETRA III HiPhaX endstation
Acta Crystallographica Section A Foundations and Advances·2023Open Access
Structural elucidation and antiviral activity of cathepsin L inhibitors with carbonyl and epoxide warheads
2023Open Access
An Optimized Approach for Serial Crystallography Using Chips
Crystals·2023Open Access
Calpeptin is a potent cathepsin inhibitor and drug candidate for SARS-CoV-2 infections
Research Square (Research Square)·2023· 3 citedOpen Access
Antiviral activity of natural phenolic compounds in complex at an allosteric site of SARS-CoV-2 papain-like protease
Communications Biology·2022· 55 citedOpen Access
Distinct actin–tropomyosin cofilament populations drive the functional diversification of cytoskeletal myosin motor complexes
iScience·2022· 36 citedOpen Access
Hydrazones and Thiosemicarbazones Targeting Protein-Protein-Interactions of SARS-CoV-2 Papain-like Protease
Frontiers in Chemistry·2022· 22 citedOpen Access
SARS-CoV-2 papain-like protease PLpro in complex with natural compounds reveal allosteric sites for antiviral drug design
2021· 3 citedOpen Access
Structure of SARS-CoV-2 papain-like protease PLpro reveals a framework for antiviral inhibitor design
Acta Crystallographica Section A Foundations and Advances·2021Open Access
page 1 of 4Next →

Frequent Co-authors

Alke Meents(36), Henry N. Chapman(32), J. Lieske(30), Sven Falke(28), Oleksandr Yefanov(25), Thomas J. Lane(24), H. Brognaro(23), F. Koua(22), D. Oberthüer(22), Luca Gelisio(22), A. Tolstikova(22), F. Trost(22), M. Galchenkova(22), Helen M. Ginn(21), S. Saouane(21), M. Groessler(21), N. Werner(21), B. Alves Franca(21), M. Schwinzer(21), B. Seychell(20)